Skip to main content
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.340
-0.028 (-7.50%)
At close: Nov 20, 2024, 4:00 PM
0.339
-0.002 (-0.44%)
Pre-market: Nov 21, 2024, 4:14 AM EST

X4 Pharmaceuticals Revenue

X4 Pharmaceuticals had revenue of $560.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $1.12M.

Revenue (ttm)
$1.12M
Revenue Growth
n/a
P/S Ratio
60.66
Revenue / Employee
$12,075
Employees
93
Market Cap
58.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20203.00M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 160.43M
Xtant Medical Holdings 113.86M
InterCure 72.42M
bluebird bio 53.12M
Champions Oncology 51.66M
Hyperfine 13.26M
VolitionRx 1.29M
Entera Bio 99.00K
Revenue Rankings

XFOR News

More News